Technology strategy revealed: Patterns and influences of patent-licensing behaviour in Japanese firms

International Journal of Technology Management

Volumn 30, Issue 3-4, 2005, Pages 327-350

  Collinson, Simon ^a   Kato, Hisaharu ^b   Yoshihara, Hitomi ^c  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b BTG International Ltd   (United Kingdom)

^c Hibiya Kokusai Building ^*  (Japan)

Author keywords

Electronics; Intellectual assets; Japanese firms; Licensing; Make or buy; Patents; Pharmaceuticals; Strategy

Indexed keywords

DECISION MAKING; DRUG PRODUCTS PLANTS; ELECTRONIC EQUIPMENT; INTELLECTUAL PROPERTY; PATENTS AND INVENTIONS; SOCIETIES AND INSTITUTIONS;

INTELLECTUAL ASSETS; JAPANESE FIRMS; LICENSING; MAKE-OR-BUY; STRATEGY;

TECHNOLOGY;

EID: 19344363965     PISSN: 02675730     EISSN: None     Source Type: Journal    
DOI: 10.1504/IJTM.2005.006732     Document Type: Article

References (41)

1. Arora, A. (1995) 'Licensing tacit knowledge: intellectual property rights and the market for know-how', Economics of Innovation and New Technology, Vol. 4, pp.41-59.
2. Arora, A. and Fosfuri, A. (2003) 'Licensing the market for technology', Journal of Economic Behavior and Organization, Vol. 52, No. 2, pp.277-296.
3. Arora, A. et al. (2001) 'Markets for technology and their implications for corporate strategy', Industrial and Corporate Change, Vol. 10, No. 2, pp.419-452.
4. Bowonder, B. et al. (2003) 'The global pharmaceutical industry: changing competitive landscape', International Journal of Technology Management, Vol. 25, Nos. 3-4.
5. Brusoni, S., Criscuolo, P. and Geuna, A. (2003) 'The knowledge bases of the world's largest pharmaceuticals groups: what do patent citations to non-patent literature reveal?', SPRU Electronic Paper Series, University of Sussex, UK: Science Policy Research Unit, No. 90.
6. Brusoni, S., Pavitt, K. and Principe, A. (2001) 'Knowledge specialisation, organisational coupling, and the boundaries of the firm: why do firms know more than they make?', Administrative Science Quarterly, Vol. 26, No. 4.
7. Buderi, R. (2000) 'Companies squeeze the patent pipeline', MIT Technology Review, Patent Scoreboard 2000, March-April, MIT.
8. Chevalier, K. and Salmon, J.W. (1998) 'International movement of Japan's pharmaceutical industry: reform of Japanese health policies, part II', Journal of Managed Care Pharmacy, Vol. 4, No. 2.
9. Cohen, W.M. et al. (2002) 'R&D spillovers, patents and the incentives to innovate in Japan and the United States', Research Policy, Vol. 31, Nos. 8-9, pp.1349-1368.
10. Collinson, S.C. (2001) 'Knowledge management capabilities in R&D: a UK-Japan company comparison', R&D Management, Vol. 31, No. 3, pp.335-347.
11. Collinson, S.C. (2003) 'Restructuring to build knowledge-integration capabilities for innovation', in P. Conceição, D.V. Gibson, M.V. Heitor and C. Stolp, (Eds.) Systems and Policies for the Global Learning Economy, Praeger, Westport.
12. Collinson, S.C. and Wilson, D.C. (2003) 'Inertia in Japanese organizations: knowledge management routines and failure to innovate', Proceedings of the American Academy of Management, 2003 Annual Conference, USA: Seattle.
13. Dixon, P. and Greenhalgh, C. (2002) 'The economics of intellectual property: a review to identify themes for future research', Working Paper for the Intellectual Property Advisory Committee (IPAC) of the UK Patent Office, Oxford: Oxford Intellectual Property Research Centre.
14. Gambardella, A. (1995) Science and Innovation in the US Pharmaceutical Industry, Cambridge: Cambridge University Press.
15. Granstrand et al. (1997) 'Multi-technology corporations: why they have distributed rather than distinctive core competencies', California Management Review, Vol. 39, pp.8-25.
16. Grant, R.M. (1996) 'Toward a knowledge-based theory of the firm', Strategic Management Journal, Winter Special Issue, Vol. 17, pp. 109-122.
17. Haneda, S. and Odagiri, H. (1998) 'Appropriation of returns from technological assets and the values of patents and R&D in Japanese high-tech firms', Economics of Innovation and New Technology, Vol. 7, No. 4, pp.303-322.
18. Jaffe, A.B. (1986) 'Technological opportunity and spillovers of R&D: evidence from firms' patents, profits and market value', American Economic Review, Vol. LXXVI, pp.984-1001.
19. Japan Intellectual Property Association (2003) How to Evaluate the Economic Value of Intellectual Property in Enterprises' (Kigyo Niokeru Titekizaisan no Keizai-Katchi-Hyouka no Arikata), http://www.iip.or.jp/e/index. html
20. Japan Patent Office (2002) Trends of Industrial Property Right Applications and Registrations, Japan: Technology Research Division, Japan Patent Office.
21. Kleinknecht, A. (1996) Determinants of Innovation; The Message from New Indicators, New York: McMillan.
22. Kruger, D. (2001) 'Survival of the fittest', Far Eastern Economic Review, Vol. 164, No. 21, pp.34-36.
23. Lanjouw, J.O. and Pakes, A. (1998) 'How to count patents and value intellectual property: the uses of patent renewal and application data', Journal of Industrial Economics, Vol. 46, No. 4.
24. Odagiri, H. (2003) 'Transaction costs and capabilities as determinants of the R&D boundaries of the firm: a case study of the ten largest pharmaceutical firms in Japan', Managerial and Decision Economics, Vol. 24, Nos. 2-3, pp. 187-202.
25. O'Donoghue, T. and Scotchmer, S. (1998) 'Patent breadth, patent life, and the pace of technological progress', Journal of Economics and Management Strategy, Vol. 7, No. 1, pp. 1-33.
26. Pakes, A. and Griliches, Z. (1984) 'Patents and R&D at the firm level: a first look', in Z. Griliches (Ed.) R&D, Patents and Productivity, Chicago: The University of Chicago Press.
27. Pakes, A. and Schankerman, M. (1984) 'The rate of obsolescence of patents, research gestation lags, and the private rate of return to research resources', in Z. Griliches (Ed.) R&D, Patents and Productivity, NBER Conference Series, Chicago: The University of Chicago Press.
28. Pavitt, K. (1984) 'Sectoral patterns of technical change', Research Policy, Vol. 13, pp.343-373.
29. Peteraf, M.A. (1993) 'The cornerstones of competitive advantage: a resource based view', Strategic Management Journal, Vol. 14, pp.179-191.
30. Pisano, G.P. (1990) 'The R&D boundaries of the firm: an empirical analysis', Administrative Science Quarterly, Vol. 35, No. 1, pp.153-176.
31. Putnam, J. (1996) 'The value of international patent protection', PhD Thesis, Yale University.
32. Rogers, M. and Greenhalgh, C. (2003) 'The value of innovation: the interaction of competition, R&D and IP', Paper Presented at What Do We Know About Innovation?, Conference in honour of Keith Pavitt, October, the Science Policy Research Unit (SPRU), The University of Sussex, UK.
33. Technology Review (2002) The TR Patent Scorecard 2002, May, Vol. 105, No. 4.
34. Teece, D.J. (1986) 'Profiting from technological innovation: implications for integration, collaboration, licensing and public policy', Research Policy, Vol. 15, No. 6, pp.285-305.
35. Teece, D.J. (1998) 'Capturing value from knowledge assets: the new economy, markets for know-how, and intangible assets', California Management Review, Vol. 40, No. 3, pp.55-80.
36. Teece, D.J. (2000) 'Strategies for managing knowledge assets: the role of firm structure and industrial context', Long Range Planning, Vol. 33, No. 1, pp.35-55.
37. Teece, D.J. (2001) Managing Intellectual Capital: Organizational, Strategic and Policy Dimensions, Oxford: Oxford University Press.
38. Torres, A. (1999) 'Unlocking the value of intellectual assets', McKinsey Quarterly, Vol. 1, pp.28-37.
39. Triendle, R. (1998) 'Japan's drug manufacturers edge toward globalization', Research Technology Management, Vol. 41, No. 5, pp.8-9.
40. Whittaker, E. and Bower, D.J. (1994) 'A shift to external alliances for product development in the pharmaceutical industry', R&D Management, Vol. 24, No. 3.
41. Woodall, B. and Yoshikawa, A. (1997) 'Japan's failure in pharmaceuticals: why is the world saying "No" to Japanese drugs?', Working Paper for Center for International Business Education and Research, Georgia Institute of Technology, pp.97-127.